Vascular dysfunction in Type 2 diabetes : emerging targets for therapy
Helping the circulatory system heal itself : manipulating kinin signaling to promote neovascularization
The Dieter Test
Power lines and implantable rhythm devices
Power lines and implantable rhythm devices : a reply
Interventionalists could be over-stenting
Proton pump inhibitors may be associated with myocardial reinfarction when taken with clopidogrel
Pilot trial suggests candesartan as a new treatment option for hypertrophic cardiomyopathy
US FDA panel judges genetically modified goat product to be safe
Brain enzyme could be new hypertension target
Monitoring BNP levels to guide heart failure therapy gives mixed results
Low sodium–potassium ratio helps reduce blood pressure
Efficacy and safety of olmesartan medoxomil alone and in combination with hydrochlorothiazide
Fondaparinux in the treatment of acute coronary syndromes : evidence from OASIS 5 and 6
Cardio–renal protection with aliskiren, a direct renin inhibitor, in the ASPIRE HIGHER program
Multidisciplinary approach for circulatory support in patients with advanced heart failure
Perils of weight loss : the advantage of being obese in patients with heart failure
Diabetes and hypertension : which is the best approach?
Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis
The emerging obesity problem in Latin America
Role of thrombectomy in acute myocardial infarction
Pathophysiology of coronary artery disease : the case for multiparametric imaging
Management of atrial fibrillation in patients with heart failure : from drug therapy to ablation